AUGMENTIN 875 MG TABLETS

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

AMOXICILLIN AS TRIHYDRATE; CLAVULANIC ACID AS POTASSIUM SALT

Available from:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC code:

J01CR01

Pharmaceutical form:

FILM COATED TABLETS

Composition:

AMOXICILLIN AS TRIHYDRATE 875 MG; CLAVULANIC ACID AS POTASSIUM SALT 125 MG

Administration route:

PER OS

Prescription type:

Required

Manufactured by:

GLAXO SMITHKLINE TRADING SERVICES LIMITED, IRELAND

Therapeutic area:

AMPICILLIN AND ENZYME INHIBITOR

Therapeutic indications:

Augmentin is indicated for the treatment of the following infections in adults and children :• Acute bacterial sinusitis (adequately diagnosed)• Acute otitis media• Acute exacerbations of chronic bronchitis (adequately diagnosed)• Community acquired pneumonia• Cystitis• Pyelonephritis• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis.• Bone and joint infections, in particular osteomyelitis.

Authorization date:

2022-09-30

Patient Information leaflet

PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’
REGULATIONS (PREPARATIONS) – 1986
The medicine is dispensed according to a physicians prescription only
AUGMENTIN 875 MG TABLETS
FILM-COATED TABLETS.
EACH TABLET CONTAINS: 875 MG AMOXICILLIN (AS TRIHYDRATE)
125 MG CLAVULANIC ACID (AS POTASSIUM SALT)
For a list of the inactive and allergenic ingredients in the
preparation, see
section 2 –
Important information about some of the ingredients of the
medicine and section 6 – Additional information.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This
leaflet
contains
concise
information
about
the
medicine.
If
you
have
further
questions, refer to the physician or the pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may
harm them even if it seems to you that their medical condition is
similar.
1. WHAT IS THE MEDICINE INTENDED FOR?
Augmentin is used in adults and children to treat the following
infections:
•
middle ear and sinus infections
•
respiratory tract infections
•
urinary tract infections
•
skin and soft tissue infections including dental infections
•
bone and joint infections.
Augmentin is an antibiotic that works by killing bacteria that cause
infections.
It contains two different medicines called amoxicillin and clavulanic
acid.
Amoxicillin belongs to a group of medicines called
penicillins whose action
can sometimes be stopped (become inactive). The other active component
(clavulanic acid) prevents this from happening.
THERAPEUTIC GROUP
Amoxicillin: Penicillin antibiotic group.
Clavulanic acid: Beta-lactamase enzyme inhibitors.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
•
you are sensitive (allergic) to amoxicillin, clavulanic acid,
penicillin or any of
the additional ingredients contained in the medicine (listed in
section 6)
•
you have ever had a severe allergic reaction to any other antibiotic.
This
can include a skin rash or swelling of the face or throat
•
you have ever had liver problems or jaundice (yellowing of t

Summary of Product characteristics

Page
1
of
15
Augmentin 875 mg Tablets
_ _
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Augmentin 875 mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film-coated tablet contains amoxicillin trihydrate equivalent to
875 mg amoxicillin and
potassium clavulanate equivalent to 125 mg of clavulanic acid.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet.
White to off-white, capsule shaped tablets debossed with “AC” on
both sides and a scoreline on one
side.
The score line is only to facilitate breaking for ease of swallowing
and not to divide into equal doses.
4.
CLINICAL PARTICULARS
4.1
Therapeutic indications
Augmentin is indicated for the treatment of the following infections
in adults and children (see sections
4.2, 4.4 and 5.1):
•
Acute bacterial sinusitis (adequately diagnosed)
•
Acute otitis media
•
Acute exacerbations of chronic bronchitis (adequately diagnosed)
•
Community acquired pneumonia
•
Cystitis
•
Pyelonephritis
•
Skin and soft tissue infections in particular cellulitis, animal
bites, severe dental abscess with
spreading cellulitis
•
Bone and joint infections, in particular osteomyelitis.
Consideration should be given to official guidance on the appropriate
use of antibacterial agents.
There are no clinical data for Augmentin 7:1 formulations for patients
under 2 months of age.
4.2
Posology and method of administration
Posology
Doses are expressed throughout in terms of amoxicillin/clavulanic acid
content except when doses are
stated in terms of an individual component.
Page
2
of
15
The dose of Augmentin that is selected to treat an individual
infection should take into account:
•
The expected pathogens and their likely susceptibility to
antibacterial agents (see section 4.4)
•
The severity and the site of the infection
•
The age, weight and renal function of the patient as shown below.
The use of alternative presentations of Augmentin (e.g. those that
provide higher doses of amoxicillin
and/or differe